The National Institutes of Health (NIH) released a study that shows a combination of two medications, injectable naltrexone and oral bupropion, is safe and effective in treating methamphetamine use disorder.
IRETA faced the challenge of switching completely to telehealth with very little notice. IRETA’s Director of Clinical Quality Improvement Services, David Reazin, MHS, answered questions about what it was like to adapt to telehealth and the pros and cons of virtual groups.
IRETA has hosted medical students in Pittsburgh for the Scaife Medical Student Fellowship in Substance Use Disorders. The fellowship offers medical students, typically between their first and second years of medical school, an intensive learning experience about substance use, addiction, and addiction treatment.
Questioning Alcohol Use as “#SelfCare.” When it comes to sleep, alcohol may help you fall asleep, but it actually disrupts sleep patterns and blocks REM sleep, causing anyone who drinks it before bed to have a less restful night’s sleep than if they hadn’t consumed alcohol.
The year 2019 was a big one for IRETA. We celebrated our 20th anniversary, held our first public symposium, increased our staff, and continued to work hard to fulfill our mission. None of our work would be possible without the organizations and individuals we partner with.